Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Ketamine in ESP Block for Mastectomy Analgesia
NCT05727098Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2023
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine, ketamine in postoperative pain, sponsored by National Cancer Institute. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05727098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05727098.